Ticker Symbol: ONCY

Oncolytics Biotech, Inc.

$1.85 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001129928

Company Profile

Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered immuno-oncolytic virus. The compound induces selective tumor lysis and promotes an inflamed tumor phenotype -- turning 'cold' tumors 'hot' -- through innate and adaptive immune responses to treat a variety of cancers.

Sector: Professional, Scientific, and Technical Services

Industry: Research and Development in Biotechnology

Standard Industrial Classification Code (SIC code): 2834

Address: N/A

Website: www.oncolyticsbiotech.com

CEO: N/A

Tags:

Health Technology
Biotechnology

Pricing

Last Updated: October 3, 2023 03:00 PM EST

Previous Close: $2.02

Change: -$0.07 ( -3.35%)

Days Range: $1.99 - $2.04

Beta: 1.15

52wk. High: $3.39

52wk. Low: $1.09

Ytd. Change 24.87%

50 Day Moving Average: $2.09

200 Day Moving Average: $2.04

Shares Outstanding: 73398847

Valuation

Market Cap: 14.6B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A